Comparative Effectiveness of Long‐Acting Beta2‐Agonist Combined with a Long‐Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive …

JC Samp, MJ Joo, GT Schumock… - … : The Journal of …, 2017 - Wiley Online Library
Introduction Several dual bronchodilator fixed‐dose inhaler medications were recently
approved for the treatment of chronic obstructive pulmonary disease (COPD). These …

Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive …

JC Samp, MJ Joo, GT Schumock… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Introduction Several dual bronchodilator fixed-dose inhaler medications were recently
approved for the treatment of chronic obstructive pulmonary disease (COPD). These …

Comparative Effectiveness of Long‐Acting Beta2‐Agonist Combined with a Long‐Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive …

JC Samp, MJ Joo, GT Schumock, GS Calip… - … : The Journal of Human …, 2017 - infona.pl
Introduction Several dual bronchodilator fixed‐dose inhaler medications were recently
approved for the treatment of chronic obstructive pulmonary disease (COPD). These …

Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive …

JC Samp, MJ Joo, GT Schumock, GS Calip… - …, 2017 - europepmc.org
Methods This was a retrospective observational study of COPD patients in the United States
treated with LABA/LAMA or LABA/ICS combination. Insurance claims from January 1, 2004 …

Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive …

JC Samp, MJ Joo, GT Schumock, GS Calip… - …, 2017 - search.ebscohost.com
Introduction Several dual bronchodilator fixed-dose inhaler medications were recently
approved for the treatment of chronic obstructive pulmonary disease (COPD). These …